Crucially, an effective supply chain requires resilience. Resilience across every facet of the pharmaceutical supply chain is paramount, whether ecological, societal, organisational, or psychological.

However, MCK faces regulatory uncertainties, inflationary pressures and potential supply-chain disruptions in the evolving global healthcare landscape. Increasing competition and shifting ...

The Healthcare Distribution Alliance, which represents companies like McKesson (NYSE:MCK), Cardinal Health ... dose medicines for greater supply chain resilience." The Association for Affordable ...

The Promoting Resilient Supply Chains Act, reintroduced by Sens. Maria Cantwell (D-Wash.) and Marsha Blackburn (R-Tenn.), gained bipartisan approval from the Commerce Committee.

Cost management is the number one priority for today’s C-suites, and a recent survey of 770 CEOs, CFOs and COOs by BCG shows that supply chain disruption is one of the top two reasons for ...

McKesson MCK has started 2025 on a positive note, with the stock climbing 4% so far in January as investors remain optimistic about the company’s performance in 2025. MCK’s growth this year ...